Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants
Top Cited Papers
Open Access
- 1 April 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 191 (7) , 1093-1104
- https://doi.org/10.1086/427813
Abstract
BackgroundRecombination technology can be used to create live attenuated respiratory syncytial virus (RSV) vaccines that contain combinations of known attenuating mutationsKeywords
This publication has 0 references indexed in Scilit: